secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amneal Pharmaceuticals, Inc. (AMRX)
CIK:        0001723128
Form:       8-K
Filed at:   2026-07-31T20:08:50+00:00
Accession:  0001140361-26-030491
Event type: m_and_a
Sentiment:  positive
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Amneal shareholders approve acquisition of Kashiv BioSciences; closing expected H2 2026
--------------------------------------------------------------------------------

- Stockholders approved Purchase Agreement to acquire 100% of Kashiv BioSciences membership interests.
- Approved issuance of 28,942,108 shares of Class A common stock to Sellers in connection with the deal.
- Vote results: Transaction Proposal 138,265,079 for, 655,759 against, 67,147 abstain; Stock Issuance Proposal 286,714,072 for, 1,791,016 against, 62,071 abstain.
- Closing expected in second half of 2026, subject to remaining conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1723128/000114036126030491/0001140361-26-030491-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1723128/000114036126030491/ef20079129_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-030491

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer